PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-6.7%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$116M
AUM Growth
+$116M
(-19%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-9.78%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
117
New
7
Increased
16
Reduced
65
Closed
5
Top Buys
| 1 |
Exagen
XGN
|
$1.36M |
| 2 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
$1.17M |
| 3 |
BioLife Solutions
BLFS
|
$973K |
| 4 |
AVGR
Avinger, Inc. Common Stock
AVGR
|
$517K |
| 5 |
Inuvo
INUV
|
$509K |
Top Sells
| 1 |
Magnite
MGNI
|
$2.09M |
| 2 |
Digital Turbine
APPS
|
$1.99M |
| 3 |
CryoPort
CYRX
|
$996K |
| 4 |
Expeditors International
EXPD
|
$797K |
| 5 |
Natera
NTRA
|
$577K |
Sector Composition
| 1 | Healthcare | 62.11% |
| 2 | Technology | 13.73% |
| 3 | Communication Services | 6.62% |
| 4 | Industrials | 5.98% |
| 5 | Consumer Staples | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vericel Corp
VCEL
$1.83B
| $6.04M | 5.21% | 398,997 -27,953 | -7% | -$423K |
|
2
NeoGenomics
NEO
$1.13B
| $5.02M | 4.32% | 262,300 -17,400 | -6% | -$333K |
|
3
Axogen
AXGN
$743M
| $3.99M | 3.44% | 319,775 -20,000 | -6% | -$250K |
|
|
4
Natera
NTRA
$23.1B
| $3.57M | 3.08% | 108,900 -17,600 | -14% | -$577K |
|
5
Veracyte
VCYT
$2.39B
| $3.56M | 3.06% | 148,130 -21,250 | -13% | -$510K |
|
|
CSII
6
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.27M | 2.82% | 68,766 -7,634 | -10% | -$363K |
|
7
Idexx Laboratories
IDXX
$51.8B
| $3.09M | 2.66% | 11,350 | – | – |
|
|
8
Magnite
MGNI
$3.7B
| $2.94M | 2.53% | 337,383 -239,717 | -42% | -$2.09M |
|
9
Abbott
ABT
$231B
| $2.9M | 2.5% | 34,611 -1,050 | -3% | -$87.9K |
|
10
OptimizeRx
OPRX
$335M
| $2.69M | 2.32% | 185,823 -26,970 | -13% | -$391K |
|
11
CareDx
CDNA
$727M
| $2.5M | 2.15% | 110,333 -16,417 | -13% | -$371K |
|
12
Rockwell Medical
RMTI
$58.9M
| $2.31M | 1.99% | 836,000 -116,800 | -12% | -$322K |
|
13
Microsoft
MSFT
$3.77T
| $2.28M | 1.96% | 16,385 -1,250 | -7% | -$174K |
|
14
Pfizer
PFE
$141B
| $2.1M | 1.81% | 58,440 +500 | +0.9% | +$18K |
|
15
LeMaitre Vascular
LMAT
$2.16B
| $2.09M | 1.8% | 61,130 | – | – |
|
16
Eli Lilly
LLY
$657B
| $2.07M | 1.78% | 18,510 -1,725 | -9% | -$193K |
|
|
IDXG
17
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $1.88M | 1.62% | 2,360,385 +433,135 | +22% | +$344K |
|
18
Sensus Healthcare
SRTS
$55.7M
| $1.86M | 1.6% | 309,881 -58,655 | -16% | -$352K |
|
|
19
BioLife Solutions
BLFS
$1.2B
| $1.85M | 1.59% | 111,250 +58,500 | +111% | +$973K |
|
20
Cantaloupe
CTLP
$797M
| $1.71M | 1.47% | 232,610 -57,750 | -20% | -$423K |
|
|
21
Digital Turbine
APPS
$455M
| $1.68M | 1.45% | 260,300 -309,000 | -54% | -$1.99M |
|
|
22
CryoPort
CYRX
$444M
| $1.68M | 1.45% | 102,600 -60,920 | -37% | -$996K |
|
23
AT&T
T
$209B
| $1.67M | 1.44% | 44,062 -7,650 | -15% | -$289K |
|
24
ANI Pharmaceuticals
ANIP
$2.03B
| $1.66M | 1.43% | 22,783 -7,017 | -24% | -$511K |
|
25
Target
TGT
$43.6B
| $1.57M | 1.35% | 14,640 -1,000 | -6% | -$107K |
|